Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Double-blind, Placebo-Controlled, Randomized Clinical Trial, Assessing Safety and Efficacy of MF101 for Hot Flushes and Menopausal Symptoms in Postmenopausal Women

NCT00906308 is registered in ClinicalTrials.gov with Bionovo as lead sponsor.

NCT NCT00906308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00906308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Double-blind, Placebo-Controlled, Randomized Clinical Trial, Assessing Safety and Efficacy of MF101 for Hot Flushes and Menopausal Symptoms in Postmenopausal Women
Lead sponsor
Bionovo
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2011
Completion date
Not reported
Enrollment
1,200 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

hot flushes, vasomotor symptoms